Nanofabrication Company Shrink Technologies to be Acquired

Shrink Technologies, Inc., a California corporation, has agreed to be acquired in a stock-for-stock transaction by AudioStocks, Inc. (OTCBB: AUIO). The companies have executed a binding letter of intent and expect to conclude the transaction by the end of May.

Shrink is dedicated to the commercial adoption of an innovative nanofabrication platform, invented by Dr. Michelle Khine, which provides for the rapid design and low-cost fabrication - on polystyrene and other biodegradable plastics - of micro and nanostructures for devices with a wide range of applications, including next generation solar cell substrates, wave guides for integrated circuits, microfluidic devices, stem cell research tools, biochips and LEDs to name a few. Shrink holds an exclusive license from the largest public university system in California which covers the right to commercialize 10 patent-pending inventions related to its technologies.

Shrink has created the PolyShrink Manufacturing Solution which utilizes the unique characteristics of PolyShrink, a shrinkable thermo-plastic material, which enables complex structures to be designed at the macro-scale, while retaining the original designs on a much smaller scale. PolyShrink based applications can be designed and prototyped in a few hours versus conventional methods using silicon or other materials that require costly equipment and labor intensive processes. Shrink creates features on PolyShrink that retract isotropically, after the application of heat, to a fraction of the original size. Because the patterned features "shrink," Shrink devices do not require high-resolution printing which is otherwise necessary to achieve such fine features. This flexible and elegant design and fabrication solution saves costs by eliminating the need for millions of dollars in cleanroom equipment and vastly improves time-to-market for products in Shrink's focused market segments.

Mark L. Baum, CEO of Shrink, commented, "For nearly two years our team has been working diligently to prepare Shrink for an introduction to the public equity markets. In that time, we executed an option agreement to license our core technologies and agreed to fund a multi-year research and development agreement with the university where our innovations were born. We are also proud to have reached a milestone agreement with the largest public university system in California which provides Shrink with an exclusive license to certain core patent-pending inventions, as well as numerous additional patent-pending inventions, all of which allow our Company to continue to work towards commercializing a plethora of innovative solutions for a number of fast growing multi-billion market segments. From a financial perspective, what is also notable in our exclusive licensing agreement is that the licensor has agreed to accept 100% of the initial licensing fees in equity, based on a $1.01 stock price."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.